RPS6KA3 and breast carcinoma: RSK1 and RSK2 isoforms were found to be strongly expressed in prostate and breast carcinomas [15] and osteosarcoma [16]; moreover, RSK2 promotes metastases of head and neck squamous cell carcinoma (HNSCC) [17].